STACK Infrastructure Delivers First Data Center in Australia, Launching a Robust APAC Portfolio 22-08-2023, 05:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

OnePiece Labs and HARVARD ALUMNI ENTREPRENEURS Announce a 17-02-2023, 21:05